carbostyril has been researched along with Pancreatitis, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cruz, VB; Konczal, LL; Tang, TY | 1 |
Borowitz, DS; Carrion, A; Freedman, SD; Goralski, JL; Hadjiliadis, D; Siracusa, CM; Srinivasan, S; Stokes, DC | 1 |
Johns, JD; Rowe, SM | 1 |
3 other study(ies) available for carbostyril and Pancreatitis, Chronic
Article | Year |
---|---|
Idiopathic chronic pancreatitis treated with ivacaftor in a CFTR carrier with methylmalonic acidemia.
Topics: Amino Acid Metabolism, Inborn Errors; Aminophenols; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Mutation; Pancreatitis, Chronic; Quinolones | 2022 |
Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor: Case Series.
Topics: Adolescent; Adult; Aminophenols; Child; Child, Preschool; Chloride Channel Agonists; Cystic Fibrosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatitis, Chronic; Quinolones; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome; Young Adult | 2018 |
The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report.
Topics: Aminophenols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Male; Pancreatitis, Chronic; Quinolones; Recurrence; Treatment Outcome; Young Adult | 2019 |